<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="publisher-id">MEDI</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Wolters Kluwer Health</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25474434</article-id><article-id pub-id-type="pmc">4616395</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000000181</article-id><article-id pub-id-type="art-access-id">00181</article-id><article-categories><subj-group subj-group-type="heading"><subject>6600</subject></subj-group><subj-group><subject>Article</subject><subject>Observational Study</subject></subj-group></article-categories><title-group><article-title>Environmental Carbon Monoxide Level Is Associated With the Level of High-Sensitivity C-Reactive Protein in Peritoneal Dialysis Patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Wen-Hung</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Yen</surname><given-names>Tzung-Hai</given-names></name><degrees>MD, PhD</degrees></contrib><contrib contrib-type="author"><name><surname>Chan</surname><given-names>Ming-Jen</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Su</surname><given-names>Yi-Jiun</given-names></name><degrees>MD</degrees></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Malindretos.</surname><given-names>Pavlos</given-names></name></contrib></contrib-group><aff>From the Department of Nephrology and Division of Clinical Toxicology (W-HH, T-HY); Department of Internal Medicine (M-JC, Y-JS), Chang Gung Memorial Hospital, Linkou; and Chang Gung University College of Medicine (W-HH, T-HY), Taoyuan, Taiwan.</aff><author-notes><corresp>Correspondence: Wen-Hung Huang, Department of Nephrology, Chang Gung Memorial Hospital, 5, Fu-Shing St., Gueishan, Taoyuan 333, Taiwan (e-mail: <email>williammedia@yahoo.com.tw</email>).</corresp></author-notes><pub-date pub-type="collection"><month>11</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>05</day><month>12</month><year>2014</year></pub-date><volume>93</volume><issue>26</issue><elocation-id>e181</elocation-id><history><date date-type="received"><day>23</day><month>6</month><year>2014</year></date><date date-type="rev-recd"><day>17</day><month>9</month><year>2014</year></date><date date-type="accepted"><day>20</day><month>9</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 Wolters Kluwer Health | Lippincott Williams &#x00026; Wilkins</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-sa/4.0"><license-p>This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0, which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-sa/4.0">http://creativecommons.org/licenses/by-sa/4.0</ext-link></license-p></license></permissions><self-uri xlink:type="simple" xlink:href="medi-93-e181.pdf"/><abstract><title>Abstract</title><p>Inflammation is highly prevalent among peritoneal dialysis (PD) patients. High-sensitivity C-reactive protein (hs-CRP) is the most widely used inflammatory marker in clinical medicine and is correlated with mortality in PD patients. Air pollution is associated with systemic inflammation. The aim of this cross-sectional study was to assess the role of air pollutants and other clinical variables on hs-CRP values in PD patients.</p><p>We recruited a total of 175 patients who had been undergoing continuous ambulatory PD or automated PD for at least 4 months and regularly followed up. Air pollution levels were recorded by a network of 27 monitoring stations near or in the patients&#x02019; living areas throughout Taiwan. The 12-month average concentrations of particulate matter (PM) with an aerodynamic diameter of &#x0003c;10 and &#x0003c;2.5&#x0200a;&#x003bc;m (PM<sub>10</sub> and PM<sub>2.5</sub>), sulfur dioxide (SO<sub>2</sub>), nitrogen dioxide (NO<sub>2</sub>), carbon monoxide (CO), and ozone (O<sub>3</sub>) were included.</p><p>In stepwise linear regression, after adjustment for related factors, white blood cell count (<italic>&#x003b2;</italic>: 0.27, 95% confidence interval [CI] [0.71, 2.11]) and CO level (<italic>&#x003b2;</italic>: 0.17, 95% CI [2.5, 21.32]) were positively associated with hs-CRP and serum albumin levels (<italic>&#x003b2;</italic>: &#x02212;0.25, 95% CI [&#x02212;13.69, &#x02212;3.96]) and normalized protein nitrogen appearance (<italic>&#x003b2;</italic>: &#x02212;0.18, 95% CI [&#x02212;17.7, &#x02212;2.51]) was negatively associated with hs-CRP. However, serum indoxyl sulfate and <italic>p</italic>-cresyl sulfate levels were not significantly associated with hs-CRP (<italic>P</italic> &#x0003e; 0.05).</p><p>In PD patients, the environmental CO level was positively correlated with hs-CRP level.</p></abstract><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>The prevalence of inflammation among peritoneal dialysis (PD) patients is high. Inflammation is a powerful predictor of mortality and cardiovascular death in patients with end-stage renal disease (ESRD). The causes of inflammation in PD patients are complex and multifactorial, including factors related or unrelated to dialysis.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> The dialysis-related factors causing chronic inflammation in PD patients include peritoneal catheter use, glucose in the dialysate, peritonitis, exit-site infection, and endotoxins/cytokines from the dialysate; those factors unrelated to dialysis include loss of residual renal function,<sup><xref rid="R2" ref-type="bibr">2</xref>&#x02013;<xref rid="R5" ref-type="bibr">5</xref></sup> accumulation of uremic toxins, other comorbidities, malnutrition, or other infections.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> Chronic kidney disease (CKD) may act as a potent stimulus of inflammation.<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref></sup> Protein-bound uremic toxins such as <italic>p</italic>-cresyl sulfate (PCS) and indoxyl sulfate (IS) are associated with atherosclerosis and endothelial dysfunction, and activation of atherosclerotic proinflammatory markers.<sup><xref rid="R8" ref-type="bibr">8</xref>&#x02013;<xref rid="R11" ref-type="bibr">11</xref></sup> C-reactive protein (CRP) is the most widely used inflammatory marker in clinical medicine. A change in residual kidney function has also been associated with an increase in CRP in PD patients.<sup><xref rid="R12" ref-type="bibr">12</xref></sup> Several other studies reported a similar association between increased CRP level and increased mortality in both hemodialysis<sup><xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref></sup> and PD patients.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R15" ref-type="bibr">15</xref>&#x02013;<xref rid="R17" ref-type="bibr">17</xref></sup> Interestingly, several studies have revealed that air pollution is associated with systemic inflammation.<sup><xref rid="R18" ref-type="bibr">18</xref>&#x02013;<xref rid="R20" ref-type="bibr">20</xref></sup> The 6 most common air pollutants are particulate matter (PM), lead (Pb), sulfur dioxide (SO<sub>2</sub>), nitrogen oxides (NO<sub><italic>x</italic></sub>), ozone (O<sub>3</sub>), and carbon monoxide (CO).<sup><xref rid="R21" ref-type="bibr">21</xref></sup> Poor air quality has a profound and lasting effect on human health, particularly on the respiratory, cardiovascular,<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup> and central nervous systems.<sup><xref rid="R24" ref-type="bibr">24</xref>&#x02013;<xref rid="R26" ref-type="bibr">26</xref></sup> In a recent study, chronic CO exposure was associated with arterial wall thickness and an elevated level of high-sensitivity CRP (hs-CRP).<sup><xref rid="R27" ref-type="bibr">27</xref></sup> To our knowledge, few studies have investigated air pollution as a dialysis-unrelated factor causing chronic inflammation in PD patients. The aim of this prospective cross-sectional study was to assess the role of air pollutants and other clinical variables on hs-CRP values in PD patients.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><p>This study was approved by the ethical committee of the Chang Gung Memorial Hospital, Linkou, Taiwan, and performed in accordance with the principles of the Declaration of Helsinki. All the data were analyzed anonymously, and all patients&#x02019; records and information were anonymized and deidentified before analysis. Furthermore, all information was securely protected (by delinking identifying information from the main data set) and available to investigators only. Finally, all primary data were collected according to the Strengthening the Reporting of Observational Studies in Epidemiology guidelines.</p><sec><title>Study Population</title><p>Initially, we randomly recruited a total of 175 patients who had been undergoing continuous ambulatory PD (CAPD) or automated PD (APD) for at least 4 months and regularly followed up at a PD center in Chang Gung Memorial Hospital. All patients were randomly recruited between October 1 and November 30, 2009. Patients with a history of dialysis-related infection or other types of active infections within 3 months before study inclusion were excluded. PD supplies (CAPD and APD solutions) were obtained from Baxter Healthcare SA, Singapore. All patients gave their informed written consent. Age, gender, and clinical data were obtained from the patients&#x02019; medical records. All medical records during the study period, including medical history, laboratory data, and inclusion and exclusion factors, were reviewed by 2 nephrology specialists (W-HH and T-HY) and 1 general physician (M-JC).</p></sec><sec><title>Sample Collection</title><p>Fasting blood, urine, and dialysate samples were collected on the same day between October 1 and November 30, 2009 during each patient's yearly routine examination, which included a peritoneal membrane function test. The plasma, dialysate, and urine concentrations of creatinine (Cr), serum albumin, and urea nitrogen were measured using routine laboratory methods. On the basis of the studies on the contributions of PCS and IS in the pathogenesis of vascular injury through endothelial dysfunction,<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup> proliferation of vascular smooth muscle cells,<sup><xref rid="R9" ref-type="bibr">9</xref></sup> activation of atherosclerotic proinflammatory markers,<sup><xref rid="R11" ref-type="bibr">11</xref></sup> and suppression of endothelial repair,<sup><xref rid="R28" ref-type="bibr">28</xref></sup> we measured the serum concentrations of total formed IS and PCS for their correlation with the hs-CRP level. Protein nitrogen appearance was normalized to body weight (nPNA). Anuria was defined as 24-hour urine volume &#x0003c;50&#x0200a;cm<sup>3</sup>. Residual renal function was calculated as follows: (renal normalized urea nitrogen clearance + renal normalized Cr clearance)/2. Owing to the lack of any definite hs-CRP cutoff level indicating an inflammatory state in PD patients, inflammation was defined as an hs-CRP level of &#x02265;10&#x0200a;mg/L, a level that has been correlated with increased mortality risk in PD patients.<sup><xref rid="R17" ref-type="bibr">17</xref></sup> Levels of the air pollutants were also categorized into high and low according to the median value of each of the 6 air pollutants. The method for testing of IS and PCS was referenced from a previous study.<sup><xref rid="R29" ref-type="bibr">29</xref></sup></p></sec><sec><title>Air Quality Status and Analysis</title><p>To verify our inference that levels of air pollutants are correlated with hs-CRP values in PD patients, we analyzed the database and cited the report on the air quality status in Taiwan, using the data from the Taiwan Air Quality Monitoring Network operated by the Environmental Protection Administration.<sup><xref rid="R30" ref-type="bibr">30</xref></sup> We recorded and analyzed the difference in air quality from the previous 12-month average exposure concentration of air pollutants according to the patients&#x02019; living areas. To the best of our knowledge, the appropriate averaging time for the air pollution effect on inflammation is unclear. Previous studies showed that the effect is spread overall for several days,<sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R31" ref-type="bibr">31</xref></sup> months,<sup><xref rid="R32" ref-type="bibr">32</xref></sup> or even years.<sup><xref rid="R33" ref-type="bibr">33</xref></sup> From the above-cited studies, we considered the previous 12-month average exposure concentration of air pollutants for each subject's examination. The referenced items included previous 12-month average concentrations of PM with an aerodynamic diameter of &#x0003c;10 and &#x0003c;2.5&#x0200a;&#x003bc;m (PM<sub>10</sub> and PM<sub>2.5</sub>), SO<sub>2</sub>, NO<sub>2</sub>, CO, and O<sub>3</sub>. Air pollution levels were recorded by a network of 27 monitoring stations near or in the patients&#x02019; living areas throughout Taiwan. The most northern living area is Hsichih District and the most southern area is Changhua City.</p></sec><sec><title>Statistical Analysis</title><p>The Kolmogorov&#x02013;Smirnov test was used to test if variables were to be normally distributed. A <italic>P</italic> value &#x0003e;0.05 was required to assume a normal distribution. Data are expressed in terms of median and interquartile range in nonnormal distribution variables and as mean&#x0200a;&#x000b1;&#x0200a;standard deviation in normal distribution variables. Comparisons between groups were performed using the Mann&#x02013;Whitney test and Student <italic>t</italic> test. &#x003c7;<sup>2</sup> or Fisher exact tests were used to analyze the correlation between categorical variables. To calculate the relative correlation of the hs-CRP value, standardized coefficients (<italic>&#x003b2;</italic>) and 95% CIs were obtained using linear regression models. Univariate and stepwise linear regression analyses were used. The following factors were investigated: PM<sub>10</sub>, SO<sub>2</sub>, NO<sub>2</sub>, CO, O<sub>3</sub>, PM<sub>2.5</sub>, age, PD duration, serum Cr level, white blood cell count (WBC), nPNA, serum albumin, serum total IS, serum total PCS, residual renal function test, intact parathyroid hormone level (iPTH), blood aluminum (Al) level, diabetes mellitus (DM), coronary artery disease (CAD), and hypertension. All the nominal variables in linear regression were transformed into dummy coding. Missing data was approached with listwise deletion. All statistical analyses were performed using the Statistical Package for the Social Sciences, version 12.0 for Windows (SPSS Inc, Chicago, IL). A <italic>P</italic> value of &#x0003c;0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec sec-type="subjects"><title>Patient Characteristics</title><p>A total of 175 patients from a single PD center were enrolled in this study. Fourteen patients received APD and 161 patients received CAPD. Table <xref ref-type="table" rid="T1">1</xref> lists the characteristics of the study subjects (mean age, 50 years). Of all patients, 125 were women and 78 patients showed anuria. Furthermore, the daily exchange volume was 9.85 L. The median hs-CRP level was 2.8&#x0200a;mg/L (range, 1.2&#x02013;7.6&#x0200a;mg/L). Fifteen patients (8.5%) were habitual users of tobacco. The median concentration of PM<sub>10</sub> was 49.1&#x0200a;&#x003bc;g/m<sup>3</sup>; SO<sub>2</sub>, 5.2 ppb; NO<sub>2</sub>, 20.1 ppb; CO, 0.53&#x0200a;ppm; O<sub>3</sub>, 28.7 ppb; and PM<sub>2.5</sub>, 29.6&#x0200a;&#x003bc;g/m<sup>3</sup>. The causes of ESRD were diabetic nephropathy (n&#x0200a;=&#x0200a;21), polycystic kidney disease (n&#x0200a;=&#x0200a;1), glomerular disease (n&#x0200a;=&#x0200a;79), malignant hypertension (n&#x0200a;=&#x0200a;15), obstructive nephropathy (n&#x0200a;=&#x0200a;3), lupus nephritis (n&#x0200a;=&#x0200a;4), gouty nephropathy (n&#x0200a;=&#x0200a;2), tubulointerstitial disease (n&#x0200a;=&#x0200a;2), and unknown factors (n&#x0200a;=&#x0200a;48).</p><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p>Characteristics of the 175 Peritoneal Dialysis Patients</p></caption><graphic xlink:href="medi-93-e181-g001"/></table-wrap></sec><sec sec-type="subjects"><title>Factors Associated With hs-CRP Level in Patients With PD</title><p>The correlation between CO and hs-CRP was revealed in Figure <xref ref-type="fig" rid="F1">1</xref> (<italic>r</italic>&#x0200a;=&#x0200a;0.16, <italic>P</italic>&#x0200a;=&#x0200a;0.03). To further investigate the correlation between inflammation (hs-CRP &#x02265;10&#x0200a;mg/L) and the 6 air pollutants, we categorized the levels into high and low levels according to each pollutant's median value and analyzed the results with the linear trend for ordinal variables analysis. The median value of PM<sub>10</sub> was 49.1&#x0200a;&#x003bc;g/m<sup>3</sup>; SO<sub>2</sub>, 5.2 ppb; NO<sub>2</sub>, 20.1 ppb; CO, 0.53&#x0200a;ppm; O<sub>3</sub>, 28.7 ppb; and PM<sub>2.5</sub>, 29.6&#x0200a;&#x003bc;g/m<sup>3</sup>. Table <xref ref-type="table" rid="T2">2</xref> shows that among the 6 air pollutants, a high level of CO was significantly (<italic>P</italic>&#x0200a;=&#x0200a;0.04) associated with a high level of hs-CRP (&#x02265;10&#x0200a;mg/L); however, all the other pollutants did not show a significant association (<italic>P</italic>&#x0200a;&#x0003e;&#x0200a;0.05). In this study, 75 patients lived in the area of higher level of CO and other 100 patients lived with contrary condition. Thirty patients had inflammation status. Except for gender, no related clinical variables were different between these 2 groups (Table <xref ref-type="table" rid="T3">3</xref>). To further clarify the factors associated with hs-CRP level in our study patients, we used univariate and multivariate linear regression &#x0201c;stepwise&#x0201d; methods, for analyses. PM<sub>10</sub>, SO<sub>2</sub>, NO<sub>2</sub>, CO, O<sub>3</sub>, PM<sub>2.5</sub>, age, PD duration, serum Cr level, WBC, nPNA, serum albumin level, serum total IS, serum total PCS, residual renal function test, iPTH, blood Al level, DM, CAD, and hypertension were investigated as clinical variables. Table <xref ref-type="table" rid="T4">4</xref> revealed that in univariate linear regression, the environmental CO level (<italic>&#x003b2;</italic>: 0.16, 95% CI [0.91, 21.27]), blood Al level (<italic>&#x003b2;</italic>: 0.16, 95% CI [0.17, 3.91]), and blood WBC (<italic>&#x003b2;</italic>: 0.24, 95% CI [0.51, 1.98]) were positively associated with hs-CRP and serum albumin levels (<italic>&#x003b2;</italic>: &#x02212;0.22, 95% CI [&#x02212;12.95, &#x02212;2.78]), and log nPNA (<italic>&#x003b2;</italic>: &#x02212;0.24, 95% CI [&#x02212;50.47, &#x02212;12.75]) was negatively associated with hs-CRP level. Except for CO, the other air pollutants were not associated with hs-CRP level (<italic>P</italic> &#x0003e; 0.05). Furthermore, in the &#x0201c;stepwise&#x0201d; model of linear regression, after adjustment for related factors, blood WBC (<italic>&#x003b2;</italic>: 0.28, 95% CI [0.73, 2.12]) and CO level (<italic>&#x003b2;</italic>: 0.17, 95% CI [2.54, 21.27]) were positively associated with hs-CRP and serum albumin levels (<italic>&#x003b2;</italic>: &#x02212;0.25, 95% CI [&#x02212;13.51, &#x02212;3.93]), and log nPNA (<italic>&#x003b2;</italic>: &#x02212;0.18, 95% CI [&#x02212;17.25, &#x02212;2.33]) was negatively associated with hs-CRP level. However, serum IS and PCS levels were not significantly associated with hs-CRP level (<italic>P</italic>&#x0200a;&#x0003e;&#x0200a;0.05).</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Relationship between airborne CO and hs-CRP (<italic>r</italic>&#x0200a;=&#x0200a;0.16, <italic>P</italic>&#x0200a;=&#x0200a;0.03). CO&#x0200a;=&#x0200a;carbon monoxide, hs-CRP&#x0200a;=&#x0200a;high-sensitivity C-reactive protein.</p></caption><graphic xlink:href="medi-93-e181-g002"/></fig><table-wrap id="T2" position="float"><label>TABLE 2</label><caption><p>Linear Trend for Ordinal Variables Analysis of Air Pollutants and hs-CRP</p></caption><graphic xlink:href="medi-93-e181-g003"/></table-wrap><table-wrap id="T3" position="float"><label>TABLE 3</label><caption><p>Comparison of Patients With Low and High-Environmental CO Exposure</p></caption><graphic xlink:href="medi-93-e181-g004"/></table-wrap><table-wrap id="T4" position="float"><label>TABLE 4</label><caption><p>Linear Regression Analysis Between Clinical Variables and hs-CRP Level (N&#x0200a;=&#x0200a;175)</p></caption><graphic xlink:href="medi-93-e181-g005"/></table-wrap></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In this study, we have shown that after adjustment for related risk factors, the level of the air pollutant CO was significantly positively associated with the level of the inflammation marker hs-CRP in PD patients.</p><p>It is well known that cardiovascular disease (CVD) is the leading cause of death in patients with ESRD, and chronic inflammation is a risk factor correlated with CVD. Inflammation is highly prevalent in the PD population. When estimated by CRP level with different cutoff values and assay sensitivities, the prevalence of inflammation varied between 12% and 65%.<sup><xref rid="R34" ref-type="bibr">34</xref></sup> The causes of inflammation in PD patients are multifactorial,<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R35" ref-type="bibr">35</xref></sup> primarily systemic infection, glucose in the dialysate, peritonitis, malnutrition, residual renal function, and accumulation uremic toxins.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R35" ref-type="bibr">35</xref></sup> Bergstrom<sup><xref rid="R36" ref-type="bibr">36</xref></sup> showed an important association between increased CRP level and increased mortality in hemodialysis patients. A number of other studies reported a similar association between increased CRP level and increased mortality in both hemodialysis<sup><xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref></sup> and PD patients.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup> Herzig et al<sup><xref rid="R15" ref-type="bibr">15</xref></sup> showed in a study of 50 PD patients that an increased CRP level was associated with an increased risk of acute myocardial infarction. Wang et al<sup><xref rid="R3" ref-type="bibr">3</xref></sup> also pointed out that an increased CRP level predicts mortality and cardiovascular death independent of other clinical, cardiovascular, dialysis, nutritional, and biochemical parameters. Iseki et al<sup><xref rid="R17" ref-type="bibr">17</xref></sup> reported that in a 5-year follow-up study, a CRP level of 10&#x0200a;mg/L or higher was associated with a &#x0003e;3-fold increased mortality in PD patients. An increased CRP level has also been shown to predict cardiovascular events in PD patients independent of other traditional and nontraditional risk factors.<sup><xref rid="R37" ref-type="bibr">37</xref></sup></p><p>Interestingly, several studies have revealed that air pollution is associated with systemic inflammation.<sup><xref rid="R18" ref-type="bibr">18</xref>&#x02013;<xref rid="R20" ref-type="bibr">20</xref></sup> The 6 most common air pollutants are PM, Pb, SO<sub>2</sub>, NO<sub><italic>x</italic></sub>, O<sub>3</sub>, and CO.<sup><xref rid="R21" ref-type="bibr">21</xref></sup> The effects of poor air quality on human health are profound and lasting, and principally affect the respiratory and cardiovascular systems.<sup><xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R23" ref-type="bibr">23</xref></sup> In addition, air pollution has been associated with increased incidence of and mortality from CAD.<sup><xref rid="R38" ref-type="bibr">38</xref></sup> In a large population and long follow-up study of 6 US cities (Harvard Six Cities study),<sup><xref rid="R22" ref-type="bibr">22</xref></sup> a significant association was noted between air pollution and mortality after adjustment for smoking, particularly in cities where pollutant levels were highest. An extended follow-up of the Harvard Six Cities study showed that cardiovascular and lung cancer mortality rates were each positively associated with fine particulate air pollution (PM<sub>2.5</sub>).<sup><xref rid="R39" ref-type="bibr">39</xref></sup></p><p>To our knowledge, reports on the association between inflammation and air pollution in PD patients are limited. In this study, we found that the CO level is positively associated with the level of hs-CRP after adjustment for related risk factors. CO is a colorless, odorless, and tasteless gas that is slightly lighter than air. It occurs in various natural and artificial environments. However, with increasing industrialization and urbanization, CO is chiefly emitted from the exhaust of internal combustion engines and industrial production, as well as from incomplete combustion of various other fuels. CO is toxic to humans and animals at higher concentrations. Acute CO poisoning is known to occur worldwide, and its major complications involve the central nervous and cardiovascular systems. However, our knowledge about the effects of chronic CO poisoning is limited, especially in PD patients. The results of chronic CO exposure in human and animal studies are conflicting. Many animal studies<sup><xref rid="R40" ref-type="bibr">40</xref>&#x02013;<xref rid="R42" ref-type="bibr">42</xref></sup> have shown that short-term and low-level CO exposure may protect against inflammatory and reactive oxygen-inducing stimuli. In other studies, intermittent CO exposure caused damage to the arterial wall and resulted in atherosclerosis.<sup><xref rid="R43" ref-type="bibr">43</xref>&#x02013;<xref rid="R45" ref-type="bibr">45</xref></sup> Epidemiological studies have shown that high levels of environmental CO were correlated with CVD and mortality.<sup><xref rid="R46" ref-type="bibr">46</xref>,<xref rid="R47" ref-type="bibr">47</xref></sup> In a recent study, Davutoglu et al<sup><xref rid="R27" ref-type="bibr">27</xref></sup> showed that hs-CRP levels and carotid intima-media thickness are increased in subjects with chronic CO exposure. The mechanism by which chronic CO exposure increases hs-CRP level is not clear. However, in the study by Davutoglu et al, one limitation is that environmental CO level and other air pollutants were not measured. From the above-cited studies, we could infer that short-term and low-level CO exposure may have anti-inflammatory effects in animals. However, chronic CO exposure may damage the arterial wall and result in atherosclerosis. In our study, we found that in PD patients, the environmental CO level was positively correlated with hs-CRP level. This result agrees with the findings of the studies cited above.</p></sec><sec sec-type="conclusion"><title>CONCLUSION</title><p>In conclusion, this cross-sectional study shows that in patients with PD, the environmental CO level is associated with the level of hs-CRP. Further studies are required to clarify the role of environmental air pollutants in inflammation and related comorbidities in PD patients.</p><sec><title>Limitations</title><p>This study has several limitations. Among them is the cross-sectional nature of the observation and that the study group is predominantly represented by women. In our PD center, the patients themselves choose between PD and HD. Considering the working environment and home-care conditions, most women chose PD. On the contrary, according to the limitations in technology and information on indoor air quality, we used the previous 1-year average air quality published by the Environmental Protection Administration Executive Yuan, Taiwan to represent the air quality of the patients&#x02019; living areas.</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to thank the members of the Statistic Center and the Peritoneal Dialysis Center, Chang Gung Memorial Hospital, Linkou, Taiwan, for their invaluable and dedicated assistance</p></ack><fn-group><fn fn-type="abbr"><p>Abbreviations: Al = blood aluminum, APD = automated PD, CAD = coronary artery disease, CAPD = continuous ambulatory PD, CKD = chronic kidney disease, CO = carbon monoxide, Cr = creatinine, CVD = cardiovascular disease, DM = diabetes mellitus, ESRD = end-stage renal disease, hs-CRP = high-sensitivity C-reactive protein, iPTH = intact parathyroid hormone, IS = indoxyl sulfate, NO<sub>2</sub> = nitrogen dioxide, nPNA = normalized protein nitrogen appearance, O<sub>3</sub> = ozone, PCS = <italic>p</italic>-cresyl sulfate, PD = peritoneal dialysis, PM = particulate matter, PM<sub>10</sub> = particulate matter with an aerodynamic diameter &#x02264;10 &#x003bc;m, PM<sub>2.5</sub> = particulate matter with an aerodynamic diameter &#x02264;2.5 &#x003bc;m, SO<sub>2</sub> = sulfur dioxide, WBC = white blood cell count.</p></fn><fn fn-type="conflict"><p>The authors have no funding and conflicts of interest to disclose.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>AY</given-names></name></person-group>
<article-title>Consequences of chronic inflammation in peritoneal dialysis</article-title>. <source><italic>Semin Nephrol</italic></source>
<year>2011</year>; <volume>31</volume>:<fpage>159</fpage>&#x02013;<lpage>171</lpage>.<pub-id pub-id-type="pmid">21439430</pub-id></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>AY</given-names></name><name><surname>Lam</surname><given-names>CW</given-names></name><name><surname>Chan</surname><given-names>IH</given-names></name><etal/></person-group>
<article-title>Long-term mortality and cardiovascular risk stratification of peritoneal dialysis patients using a combination of inflammation and calcification markers</article-title>. <source><italic>Nephrol Dial Transplant</italic></source>
<year>2009</year>; <volume>24</volume>:<fpage>3826</fpage>&#x02013;<lpage>3833</lpage>.<pub-id pub-id-type="pmid">19574337</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>AY</given-names></name><name><surname>Woo</surname><given-names>J</given-names></name><name><surname>Lam</surname><given-names>CW</given-names></name><etal/></person-group>
<article-title>Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?</article-title>
<source><italic>J Am Soc Nephrol</italic></source>
<year>2003</year>; <volume>14</volume>:<fpage>1871</fpage>&#x02013;<lpage>1879</lpage>.<pub-id pub-id-type="pmid">12819248</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>AY</given-names></name><name><surname>Lam</surname><given-names>CW</given-names></name><name><surname>Chan</surname><given-names>IH</given-names></name><etal/></person-group>
<article-title>Prognostic value of plasma myeloperoxidase in ESRD patients</article-title>. <source><italic>Am J Kidney Dis</italic></source>
<year>2010</year>; <volume>56</volume>:<fpage>937</fpage>&#x02013;<lpage>946</lpage>.<pub-id pub-id-type="pmid">20638167</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>AY</given-names></name><name><surname>Lam</surname><given-names>CW</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients</article-title>. <source><italic>Am J Kidney Dis</italic></source>
<year>2005</year>; <volume>45</volume>:<fpage>715</fpage>&#x02013;<lpage>729</lpage>.<pub-id pub-id-type="pmid">15806475</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glorieux</surname><given-names>G</given-names></name><name><surname>Cohen</surname><given-names>G</given-names></name><name><surname>Jankowski</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Platelet/leukocyte activation, inflammation, and uremia</article-title>. <source><italic>Semin Dial</italic></source>
<year>2009</year>; <volume>22</volume>:<fpage>423</fpage>&#x02013;<lpage>427</lpage>.<pub-id pub-id-type="pmid">19708994</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbelin</surname><given-names>A</given-names></name><name><surname>Urena</surname><given-names>P</given-names></name><name><surname>Nguyen</surname><given-names>AT</given-names></name><etal/></person-group>
<article-title>Elevated circulating levels of interleukin-6 in patients with chronic renal failure</article-title>. <source><italic>Kidney Int</italic></source>
<year>1991</year>; <volume>39</volume>:<fpage>954</fpage>&#x02013;<lpage>960</lpage>.<pub-id pub-id-type="pmid">2067212</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Kang</surname><given-names>DH</given-names></name></person-group>
<article-title>Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress</article-title>. <source><italic>Clin J Am Soc Nephrol</italic></source>
<year>2011</year>; <volume>6</volume>:<fpage>30</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">20876676</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Hirose</surname><given-names>Y</given-names></name><name><surname>Nishijima</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>ROS and PDGF-beta [corrected] receptors are critically involved in indoxyl sulfate actions that promote vascular smooth muscle cell proliferation and migration</article-title>. <source><italic>Am J Physiol Cell Physiol</italic></source>
<year>2009</year>; <volume>297</volume>:<fpage>C389</fpage>&#x02013;<lpage>396</lpage>.<pub-id pub-id-type="pmid">19494236</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijers</surname><given-names>BK</given-names></name><name><surname>Van Kerckhoven</surname><given-names>S</given-names></name><name><surname>Verbeke</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>The uremic retention solute p-cresyl sulfate and markers of endothelial damage</article-title>. <source><italic>Am J Kidney Dis</italic></source>
<year>2009</year>; <volume>54</volume>:<fpage>891</fpage>&#x02013;<lpage>901</lpage>.<pub-id pub-id-type="pmid">19615803</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>L</given-names></name><name><surname>Jourde-Chiche</surname><given-names>N</given-names></name><name><surname>Faure</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells</article-title>. <source><italic>J Thromb Haemost</italic></source>
<year>2007</year>; <volume>5</volume>:<fpage>1302</fpage>&#x02013;<lpage>1308</lpage>.<pub-id pub-id-type="pmid">17403109</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>SH</given-names></name><name><surname>Heimburger</surname><given-names>O</given-names></name><name><surname>Stenvinkel</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis</article-title>. <source><italic>Nephrol Dial Transplant</italic></source>
<year>2001</year>; <volume>16</volume>:<fpage>2240</fpage>&#x02013;<lpage>2245</lpage>.<pub-id pub-id-type="pmid">11682675</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>J</given-names></name><name><surname>Herrlinger</surname><given-names>S</given-names></name><name><surname>Pruy</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Inflammation enhances cardiovascular risk and mortality in hemodialysis patients</article-title>. <source><italic>Kidney Int</italic></source>
<year>1999</year>; <volume>55</volume>:<fpage>648</fpage>&#x02013;<lpage>658</lpage>.<pub-id pub-id-type="pmid">9987089</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanner</surname><given-names>C</given-names></name><name><surname>Metzger</surname><given-names>T</given-names></name></person-group>
<article-title>C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients</article-title>. <source><italic>Nephrol Dial Transplant</italic></source>
<year>2002</year>; <volume>17</volume>
<issue>Suppl 8</issue>:<fpage>29</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">12147774</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herzig</surname><given-names>KA</given-names></name><name><surname>Purdie</surname><given-names>DM</given-names></name><name><surname>Chang</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?</article-title>
<source><italic>J Am Soc Nephrol</italic></source>
<year>2001</year>; <volume>12</volume>:<fpage>814</fpage>&#x02013;<lpage>821</lpage>.<pub-id pub-id-type="pmid">11274243</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noh</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>SW</given-names></name><name><surname>Kang</surname><given-names>SW</given-names></name><etal/></person-group>
<article-title>Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients</article-title>. <source><italic>Perit Dial Int</italic></source>
<year>1998</year>; <volume>18</volume>:<fpage>387</fpage>&#x02013;<lpage>394</lpage>.<pub-id pub-id-type="pmid">10505560</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iseki</surname><given-names>K</given-names></name><name><surname>Tozawa</surname><given-names>M</given-names></name><name><surname>Yoshi</surname><given-names>S</given-names></name><name><surname>Fukiyama</surname><given-names>K</given-names></name></person-group>
<article-title>Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients</article-title>. <source><italic>Nephrol Dial Transplant</italic></source>
<year>1999</year>; <volume>14</volume>:<fpage>1956</fpage>&#x02013;<lpage>1960</lpage>.<pub-id pub-id-type="pmid">10462277</pub-id></mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rich</surname><given-names>DQ</given-names></name><name><surname>Kipen</surname><given-names>HM</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Association between changes in air pollution levels during the Beijing Olympics and biomarkers of inflammation and thrombosis in healthy young adults</article-title>. <source><italic>JAMA</italic></source>
<year>2012</year>; <volume>307</volume>:<fpage>2068</fpage>&#x02013;<lpage>2078</lpage>.<pub-id pub-id-type="pmid">22665106</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bind</surname><given-names>MA</given-names></name><name><surname>Baccarelli</surname><given-names>A</given-names></name><name><surname>Zanobetti</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Air pollution and markers of coagulation, inflammation, and endothelial function: associations and epigene-environment interactions in an elderly cohort</article-title>. <source><italic>Epidemiology</italic></source>
<year>2012</year>; <volume>23</volume>:<fpage>332</fpage>&#x02013;<lpage>340</lpage>.<pub-id pub-id-type="pmid">22237295</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexeeff</surname><given-names>SE</given-names></name><name><surname>Coull</surname><given-names>BA</given-names></name><name><surname>Gryparis</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Medium-term exposure to traffic-related air pollution and markers of inflammation and endothelial function</article-title>. <source><italic>Environ Health Perspect</italic></source>
<year>2011</year>; <volume>119</volume>:<fpage>481</fpage>&#x02013;<lpage>486</lpage>.<pub-id pub-id-type="pmid">21349799</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samet</surname><given-names>JM</given-names></name></person-group>
<article-title>The Clean Air Act and health&#x02014;a clearer view from 2011</article-title>. <source><italic>N Engl J Med</italic></source>
<year>2011</year>; <volume>365</volume>:<fpage>198</fpage>&#x02013;<lpage>201</lpage>.<pub-id pub-id-type="pmid">21732828</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dockery</surname><given-names>DW</given-names></name><name><surname>Pope</surname><given-names>CA</given-names><suffix>3rd</suffix></name><name><surname>Xu</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>An association between air pollution and mortality in six U.S. cities</article-title>. <source><italic>N Engl J Med</italic></source>
<year>1993</year>; <volume>329</volume>:<fpage>1753</fpage>&#x02013;<lpage>1759</lpage>.<pub-id pub-id-type="pmid">8179653</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dockery</surname><given-names>DW</given-names></name><name><surname>Stone</surname><given-names>PH</given-names></name></person-group>
<article-title>Cardiovascular risks from fine particulate air pollution</article-title>. <source><italic>N Engl J Med</italic></source>
<year>2007</year>; <volume>356</volume>:<fpage>511</fpage>&#x02013;<lpage>513</lpage>.<pub-id pub-id-type="pmid">17267912</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateen</surname><given-names>FJ</given-names></name><name><surname>Brook</surname><given-names>RD</given-names></name></person-group>
<article-title>Air pollution as an emerging global risk factor for stroke</article-title>. <source><italic>JAMA</italic></source>
<year>2011</year>; <volume>305</volume>:<fpage>1240</fpage>&#x02013;<lpage>1241</lpage>.<pub-id pub-id-type="pmid">21427378</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>SS</given-names></name><name><surname>Goggins</surname><given-names>WB</given-names></name><name><surname>Chiu</surname><given-names>HF</given-names></name><name><surname>Yang</surname><given-names>CY</given-names></name></person-group>
<article-title>Evidence for an association between air pollution and daily stroke admissions in Kaohsiung, Taiwan</article-title>. <source><italic>Stroke</italic></source>
<year>2003</year>; <volume>34</volume>:<fpage>2612</fpage>&#x02013;<lpage>2616</lpage>.<pub-id pub-id-type="pmid">14551399</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>KA</given-names></name><name><surname>Siscovick</surname><given-names>DS</given-names></name><name><surname>Sheppard</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Long-term exposure to air pollution and incidence of cardiovascular events in women</article-title>. <source><italic>N Engl J Med</italic></source>
<year>2007</year>; <volume>356</volume>:<fpage>447</fpage>&#x02013;<lpage>458</lpage>.<pub-id pub-id-type="pmid">17267905</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davutoglu</surname><given-names>V</given-names></name><name><surname>Zengin</surname><given-names>S</given-names></name><name><surname>Sari</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Chronic carbon monoxide exposure is associated with the increases in carotid intima-media thickness and C-reactive protein level</article-title>. <source><italic>Tohoku J Exp Med</italic></source>
<year>2009</year>; <volume>219</volume>:<fpage>201</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="pmid">19851048</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>L</given-names></name><name><surname>Bertrand</surname><given-names>E</given-names></name><name><surname>Cerini</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair</article-title>. <source><italic>Kidney Int</italic></source>
<year>2004</year>; <volume>65</volume>:<fpage>442</fpage>&#x02013;<lpage>451</lpage>.<pub-id pub-id-type="pmid">14717914</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>WH</given-names></name><name><surname>Hung</surname><given-names>CC</given-names></name><name><surname>Yang</surname><given-names>CW</given-names></name><name><surname>Huang</surname><given-names>JY</given-names></name></person-group>
<article-title>High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients</article-title>. <source><italic>Ther Apher Dial</italic></source>
<year>2012</year>; <volume>16</volume>:<fpage>361</fpage>&#x02013;<lpage>367</lpage>.<pub-id pub-id-type="pmid">22817125</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="book"><source>Taiwan Air Quality Monitoring Network (TAQMN) operated by the Environmental Protection Administration (EPA). Air quality monitoring data of 2008 and 2009</source>. <comment><ext-link ext-link-type="uri" xlink:href="http://taqm.epa.gov.tw/taqm/zh-tw/default.aspx">http://taqm.epa.gov.tw/taqm/zh-tw/default.aspx</ext-link></comment>
<date-in-citation>Accessed January 6, 2014</date-in-citation></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Frohlich</surname><given-names>M</given-names></name><name><surname>Doring</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study</article-title>. <source><italic>Eur Heart J</italic></source>
<year>2001</year>; <volume>22</volume>:<fpage>1198</fpage>&#x02013;<lpage>1204</lpage>.<pub-id pub-id-type="pmid">11440492</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanobetti</surname><given-names>A</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Samoli</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>The temporal pattern of respiratory and heart disease mortality in response to air pollution</article-title>. <source><italic>Environ Health Perspect</italic></source>
<year>2003</year>; <volume>111</volume>:<fpage>1188</fpage>&#x02013;<lpage>1193</lpage>.<pub-id pub-id-type="pmid">12842772</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panasevich</surname><given-names>S</given-names></name><name><surname>Leander</surname><given-names>K</given-names></name><name><surname>Rosenlund</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Associations of long- and short-term air pollution exposure with markers of inflammation and coagulation in a population sample</article-title>. <source><italic>Occup Environ Med</italic></source>
<year>2009</year>; <volume>66</volume>:<fpage>747</fpage>&#x02013;<lpage>753</lpage>.<pub-id pub-id-type="pmid">19687019</pub-id></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>AY</given-names></name></person-group>
<article-title>Prognostic value of C-reactive protein for heart disease in dialysis patients</article-title>. <source><italic>Curr Opin Investig Drugs</italic></source>
<year>2005</year>; <volume>6</volume>:<fpage>879</fpage>&#x02013;<lpage>886</lpage>.</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>KN</given-names></name><name><surname>Leung</surname><given-names>JC</given-names></name></person-group>
<article-title>Inflammation in peritoneal dialysis</article-title>. <source><italic>Nephron Clin Pract</italic></source>
<year>2010</year>; <volume>116</volume>:<fpage>c11</fpage>&#x02013;<lpage>c18</lpage>.<pub-id pub-id-type="pmid">20460934</pub-id></mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstrom</surname><given-names>J</given-names></name></person-group>
<article-title>Inflammation, malnutrition, cardiovascular disease and mortality in end-stage renal disease</article-title>. <source><italic>Pol Arch Med Wewn</italic></source>
<year>2000</year>; <volume>104</volume>:<fpage>641</fpage>&#x02013;<lpage>643</lpage>.<pub-id pub-id-type="pmid">11392151</pub-id></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ducloux</surname><given-names>D</given-names></name><name><surname>Bresson-Vautrin</surname><given-names>C</given-names></name><name><surname>Kribs</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>C-reactive protein and cardiovascular disease in peritoneal dialysis patients</article-title>. <source><italic>Kidney Int</italic></source>
<year>2002</year>; <volume>62</volume>:<fpage>1417</fpage>&#x02013;<lpage>1422</lpage>.<pub-id pub-id-type="pmid">12234314</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>WQ</given-names></name><name><surname>Davies</surname><given-names>HW</given-names></name><name><surname>Koehoorn</surname><given-names>M</given-names></name><name><surname>Brauer</surname><given-names>M</given-names></name></person-group>
<article-title>Association of long-term exposure to community noise and traffic-related air pollution with coronary heart disease mortality</article-title>. <source><italic>Am J Epidemiol</italic></source>
<year>2012</year>; <volume>175</volume>:<fpage>898</fpage>&#x02013;<lpage>906</lpage>.<pub-id pub-id-type="pmid">22491084</pub-id></mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laden</surname><given-names>F</given-names></name><name><surname>Schwartz</surname><given-names>J</given-names></name><name><surname>Speizer</surname><given-names>FE</given-names></name><name><surname>Dockery</surname><given-names>DW</given-names></name></person-group>
<article-title>Reduction in fine particulate air pollution and mortality: extended follow-up of the Harvard Six Cities study</article-title>. <source><italic>Am J Respir Crit Care Med</italic></source>
<year>2006</year>; <volume>173</volume>:<fpage>667</fpage>&#x02013;<lpage>672</lpage>.<pub-id pub-id-type="pmid">16424447</pub-id></mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>LA</given-names></name><name><surname>Channell</surname><given-names>MM</given-names></name><name><surname>Royer</surname><given-names>CM</given-names></name><etal/></person-group>
<article-title>Evaluation of inhaled carbon monoxide as an anti-inflammatory therapy in a nonhuman primate model of lung inflammation</article-title>. <source><italic>Am J Physiol Lung Cell Mol Physiol</italic></source>
<year>2010</year>; <volume>299</volume>:<fpage>L891</fpage>&#x02013;<lpage>897</lpage>.<pub-id pub-id-type="pmid">20729385</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wunder</surname><given-names>C</given-names></name><name><surname>Brock</surname><given-names>RW</given-names></name><name><surname>Frantz</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Carbon monoxide, but not endothelin-1, plays a major role for the hepatic microcirculation in a murine model of early systemic inflammation</article-title>. <source><italic>Crit Care Med</italic></source>
<year>2005</year>; <volume>33</volume>:<fpage>2323</fpage>&#x02013;<lpage>2331</lpage>.<pub-id pub-id-type="pmid">16215388</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sass</surname><given-names>G</given-names></name><name><surname>Soares</surname><given-names>MC</given-names></name><name><surname>Yamashita</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Heme oxygenase-1 and its reaction product, carbon monoxide, prevent inflammation-related apoptotic liver damage in mice</article-title>. <source><italic>Hepatology</italic></source>
<year>2003</year>; <volume>38</volume>:<fpage>909</fpage>&#x02013;<lpage>918</lpage>.<pub-id pub-id-type="pmid">14512878</pub-id></mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astrup</surname><given-names>P</given-names></name><name><surname>Kjeldsen</surname><given-names>K</given-names></name><name><surname>Wanstrup</surname><given-names>J</given-names></name></person-group>
<article-title>Enhancing influence of carbon monoxide on the development of atheromatosis in cholesterol-fed rabbits</article-title>. <source><italic>J Atheroscler Res</italic></source>
<year>1967</year>; <volume>7</volume>:<fpage>343</fpage>&#x02013;<lpage>354</lpage>.<pub-id pub-id-type="pmid">6036104</pub-id></mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astrup</surname><given-names>P</given-names></name><name><surname>Kjeldsen</surname><given-names>K</given-names></name><name><surname>Wanstrup</surname><given-names>J</given-names></name></person-group>
<article-title>Effects of carbon monoxide exposure on the arterial walls</article-title>. <source><italic>Ann N Y Acad Sci</italic></source>
<year>1970</year>; <volume>174</volume>:<fpage>294</fpage>&#x02013;<lpage>300</lpage>.<pub-id pub-id-type="pmid">5289606</pub-id></mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>CJ</given-names></name><name><surname>Steichen</surname><given-names>TJ</given-names></name></person-group>
<article-title>The atherogenic potential of carbon monoxide</article-title>. <source><italic>Atherosclerosis</italic></source>
<year>1993</year>; <volume>99</volume>:<fpage>137</fpage>&#x02013;<lpage>149</lpage>.<pub-id pub-id-type="pmid">8503943</pub-id></mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>FB</given-names></name><name><surname>Halperin</surname><given-names>WE</given-names></name><name><surname>Hornung</surname><given-names>RW</given-names></name><etal/></person-group>
<article-title>Heart disease mortality among bridge and tunnel officers exposed to carbon monoxide</article-title>. <source><italic>Am J Epidemiol</italic></source>
<year>1988</year>; <volume>128</volume>:<fpage>1276</fpage>&#x02013;<lpage>1288</lpage>.<pub-id pub-id-type="pmid">2461656</pub-id></mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinman</surname><given-names>MT</given-names></name><name><surname>Davidson</surname><given-names>DM</given-names></name><name><surname>Vandagriff</surname><given-names>RB</given-names></name><etal/></person-group>
<article-title>Effects of short-term exposure to carbon monoxide in subjects with coronary artery disease</article-title>. <source><italic>Arch Environ Health</italic></source>
<year>1989</year>; <volume>44</volume>:<fpage>361</fpage>&#x02013;<lpage>369</lpage>.<pub-id pub-id-type="pmid">2692521</pub-id></mixed-citation></ref></ref-list></back></article>